ACTRN12619001781134已完成未知
An open access trial examining the effects of an individually-tailored, web-based parenting program (Partners in Parenting) for parents of 12-to-17-year-olds to reduce risk and protective factors for adolescent depression and anxiety disorders.
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 741
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Prevention
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •Parent or guardian of at least one child aged 12 to 17 years (inclusive) at baseline, who reside in Australia, consider themselves fluent in English, and have internet access and an email account.
排除标准
- •No exclusion criteria specified.
- •We will not exclude parents who report clinically elevated symptoms of anxiety or depression in their adolescents at baseline. However, by assessing baseline symptoms, we will be able to conduct subsidiary subgroup analyses of parents of adolescents above/below clinical cut-off scores on the symptom measures, to examine the program effects on these subgroups.
- •The cut-off scores used to determine symptom elevation will be based on published cut-off scores, as follows:
- •SMFQ-P total score of 8 or greater.
- •RCADS-P anxiety subscale T-score of 70 or greater.
研究者
相似试验
尚未招募
2 期
Methylphenidate for Borderline Personality Disorder in AdolescentsACTRN12609001013257Concord Hospital, Department of Psychiatry30
已完成
不适用
An open trial regarding the safety and efficacy of blonanserin for patients with gambling disorderGambling disorderJPRN-UMIN000020669Chiba University3
进行中（未招募）
不适用
A trial investigating the efficacy and safety of insulin degludec/insulin aspart once daily plus insulin aspart for the remaining meals versus insulin detemir once or twice daily plus meal time insulin aspart in children and adolescents with type 1 diabetes mellitusDiabetes Mellitus, Type 1EUCTR2012-003566-41-BEovo Nordisk A/S346
进行中（未招募）
不适用
A trial investigating the efficacy and safety of insulin degludec/insulin aspart once daily plus insulin aspart for the remaining meals versus insulin detemir once or twice daily plus meal time insulin aspart in children and adolescents with type 1 diabetes mellitusDiabetes Mellitus, Type 1MedDRA version: 16.0Level: LLTClassification code 10045228Term: Type I diabetes mellitusSystem Organ Class: 100000004861EUCTR2012-003566-41-SIovo Nordisk A/S346
进行中（未招募）
不适用
A trial investigating the efficacy and safety of insulin degludec/insulin aspart once daily plus insulin aspart for the remaining meals versus insulin detemir once or twice daily plus meal time insulin aspart in children and adolescents with type 1 diabetes mellitusDiabetes Mellitus, Type 1EUCTR2012-003566-41-HRovo Nordisk A/S346